(2S,3R)-N-(3-(acetimidamidomethyl)benzyl)-2-amino-3-hydroxybutanamide dihydrochloride

ID: ALA4162963

Chembl Id: CHEMBL4162963

PubChem CID: 145959991

Max Phase: Preclinical

Molecular Formula: C14H24Cl2N4O2

Molecular Weight: 278.36

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=N)NCc1cccc(CNC(=O)[C@@H](N)[C@@H](C)O)c1.Cl.Cl

Standard InChI:  InChI=1S/C14H22N4O2.2ClH/c1-9(19)13(16)14(20)18-8-12-5-3-4-11(6-12)7-17-10(2)15;;/h3-6,9,13,19H,7-8,16H2,1-2H3,(H2,15,17)(H,18,20);2*1H/t9-,13+;;/m1../s1

Standard InChI Key:  GNRMBRQQPWBABU-OIYPRRECSA-N

Associated Targets(non-human)

NOS3 Nitric-oxide synthase, endothelial (692 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Nos2 Nitric oxide synthase, inducible (3573 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 278.36Molecular Weight (Monoisotopic): 278.1743AlogP: 0.10#Rotatable Bonds: 6
Polar Surface Area: 111.23Molecular Species: BASEHBA: 4HBD: 5
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 6#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 12.16CX LogP: -1.00CX LogD: -4.05
Aromatic Rings: 1Heavy Atoms: 20QED Weighted: 0.38Np Likeness Score: 0.07

References

1. Maccallini C, Di Matteo M, Gallorini M, Montagnani M, Graziani V, Ammazzalorso A, Amoia P, De Filippis B, Di Silvestre S, Fantacuzzi M, Giampietro L, Potenza MA, Re N, Pandolfi A, Cataldi A, Amoroso R..  (2018)  Discovery of N-{3-[(ethanimidoylamino)methyl]benzyl}-l-prolinamide dihydrochloride: A new potent and selective inhibitor of the inducible nitric oxide synthase as a promising agent for the therapy of malignant glioma.,  152  [PMID:29689474] [10.1016/j.ejmech.2018.04.027]

Source